Hikma Pharmaceuticals PLC
LSE:HIK

Watchlist Manager
Hikma Pharmaceuticals PLC Logo
Hikma Pharmaceuticals PLC
LSE:HIK
Watchlist
Price: 1 794 GBX -0.83% Market Closed
Market Cap: 4B GBX
Have any thoughts about
Hikma Pharmaceuticals PLC?
Write Note

Hikma Pharmaceuticals PLC
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hikma Pharmaceuticals PLC
PP&E Net Peer Comparison

Comparables:
GSK
AZN
VRNA
INDV
DPH

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Hikma Pharmaceuticals PLC
LSE:HIK
PP&E Net
$1.1B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
10%
GlaxoSmithKline PLC
LSE:GSK
PP&E Net
ÂŁ9.8B
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
1%
AstraZeneca PLC
LSE:AZN
PP&E Net
$10.8B
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
6%
Verona Pharma PLC
NASDAQ:VRNA
PP&E Net
$2m
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Indivior PLC
LSE:INDV
PP&E Net
$107m
CAGR 3-Years
3%
CAGR 5-Years
0%
CAGR 10-Years
23%
Dechra Pharmaceuticals PLC
LSE:DPH
PP&E Net
ÂŁ159.3m
CAGR 3-Years
28%
CAGR 5-Years
29%
CAGR 10-Years
26%

See Also

What is Hikma Pharmaceuticals PLC's PP&E Net?
PP&E Net
1.1B USD

Based on the financial report for Jun 30, 2024, Hikma Pharmaceuticals PLC's PP&E Net amounts to 1.1B USD.

What is Hikma Pharmaceuticals PLC's PP&E Net growth rate?
PP&E Net CAGR 10Y
10%

Over the last year, the PP&E Net growth was 5%. The average annual PP&E Net growth rates for Hikma Pharmaceuticals PLC have been 2% over the past three years , 5% over the past five years , and 10% over the past ten years .

Back to Top